Strata Skin Sciences, INC 8-K filings

STRATA Skin Sciences announced its fourth quarter and full-year 2023 financial results, highlighting a strategic shift towards recurring revenue and the launch of a new acne treatment device, while also reporting a net loss.

STRATA Skin Sciences successfully amended its credit agreement with MidCap Financial, removing 2023 minimum revenue requirements and introducing new financial covenants to improve liquidity and align with future business operations.

STRATA Skin Sciences has amended its credit agreement with MidCap Financial Trust, obtaining a waiver for a prior revenue covenant breach and adjusting future financial targets.